Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
293,692
-
Share change
-
-374,543
-
Total reported value
-
$1,020,000
-
Price per share
-
$3.48
-
Number of holders
-
13
-
Value change
-
-$1,852,818
-
Number of buys
-
5
-
Number of sells
-
10
Institutional Holders of VASCULAR BIOGENICS LTD - COM (VBLT) as of Q1 2016
As of 31 Mar 2016,
VASCULAR BIOGENICS LTD - COM (VBLT) was held by
13 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
293,692 shares.
The largest 10 holders included
First Eagle Investment Management, LLC, Menta Capital LLC, Smith Asset Management Group LP, BOOTHBAY FUND MANAGEMENT, LLC, ATHENA CAPITAL ADVISORS LLC, A.R.T. Advisors, LLC, DEUTSCHE BANK AG\, MORGAN STANLEY, Creative Planning, and Burt Wealth Advisors.
This page lists
13
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.